4.8 Article

Patients with autism spectrum disorders display reproducible functional connectivity alterations

期刊

SCIENCE TRANSLATIONAL MEDICINE
卷 11, 期 481, 页码 -

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.aat9223

关键词

-

资金

  1. EU AIMS LEAP
  2. EU AIMS-2-TRIALS
  3. IMI Joint Undertaking (JU) [115300]
  4. European Union's Seventh Framework Programme (FP7/2007-2013)
  5. European Federation of Pharmaceutical Industries and Associations (EFPIA) companies'
  6. Autism Speaks
  7. IMI 2 JU [777394]
  8. NIMH [K23MH087770, R03MH096321, 5R21MH107045]
  9. Nathan S. Kline Institute of Psychiatric Research
  10. Inserm
  11. Institut Roche
  12. Investissements d'Avenir program [ANR-11-IDEX-0004-02]
  13. MRC [MR/N026063/1] Funding Source: UKRI

向作者/读者索取更多资源

Despite the high clinical burden, little is known about pathophysiology underlying autism spectrum disorder (ASD). Recent resting-state functional magnetic resonance imaging (rs-fMRI) studies have found atypical synchronization of brain activity in ASD. However, no consensus has been reached on the nature and clinical relevance of these alterations. Here, we addressed these questions in four large ASD cohorts. Using rs-fMRI, we identified functional connectivity alterations associated with ASD. We tested for associations of these imaging phenotypes with clinical and demographic factors such as age, sex, medication status, and clinical symptom severity. Our results showed reproducible patterns of ASD-associated functional hyper- and hypoconnectivity. Hypoconnectivity was primarily restricted to sensory-motor regions, whereas hyperconnectivity hubs were predominately located in prefrontal and parietal cortices. Shifts in cortico-cortical between-network connectivity from outside to within the identified regions were shown to be a key driver of these abnormalities. This reproducible pathophysiological phenotype was partially associated with core ASD symptoms related to communication and daily living skills and was not affected by age, sex, or medication status. Although the large effect sizes in standardized cohorts are encouraging with respect to potential application as a treatment and for patient stratification, the moderate link to clinical symptoms and the large overlap with healthy controls currently limit the usability of identified alterations as diagnostic or efficacy readout.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据